Cargando…

CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease

Since its discovery in 2012, CRISPR Cas9 has been tried as a direct treatment approach to correct the causative gene mutation and establish animal models in neurodegenerative disorders. Since no strategy developed until now could completely cure Parkinson's disease (PD), neuroscientists aspire...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinjala, Poojitha, Tryphena, Kamatham Pushpa, Prasad, Renuka, Khatri, Dharmendra Kumar, Sun, Woong, Singh, Shashi Bala, Gugulothu, Dalapathi, Srivastava, Saurabh, Vora, Lalitkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190035/ https://www.ncbi.nlm.nih.gov/pubmed/37194005 http://dx.doi.org/10.1186/s40824-023-00381-y

Ejemplares similares

Microtubule acetylation dyshomeostasis in Parkinson’s disease
por: Naren, Padmashri, et al.
Publicado: (2023)

Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy
por: Khatri, Dharmendra K., et al.
Publicado: (2023)

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease
por: Tryphena, Kamatham Pushpa, et al.
Publicado: (2023)

CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
por: Sahel, Deepak Kumar, et al.
Publicado: (2023)

CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
por: Sahel, Deepak Kumar, et al.
Publicado: (2023)

Epigenetics in depression and gut-brain axis: A molecular crosstalk
por: Begum, Nusrat, et al.
Publicado: (2022)

Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
por: Naren, Padmashri, et al.
Publicado: (2023)

Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders()
por: Khatri, Dharmendra Kumar, et al.
Publicado: (2021)

Does skin permeation kinetics influence efficacy of topical dermal drug delivery system?: Assessment, prediction, utilization, and integration of chitosan biomacromolecule for augmenting topical dermal drug delivery in skin
por: Iyer, Akshaya, et al.
Publicado: (2021)

Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson’s Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk
por: Shirgadwar, Shubhendu M., et al.
Publicado: (2023)

FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling
por: Arias-Fuenzalida, Jonathan, et al.
Publicado: (2017)

Efficient Screening of CRISPR/Cas9-Induced Events in Drosophila Using a Co-CRISPR Strategy
por: Kane, Nanci S., et al.
Publicado: (2016)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022)

CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics
por: Kumar, Prashant, et al.
Publicado: (2020)

GSK2606414 attenuates PERK/p-eIF2α/ATF4/CHOP axis and augments mitochondrial function to mitigate high glucose induced neurotoxicity in N2A cells
por: Gundu, Chayanika, et al.
Publicado: (2022)

Hybrid Multitask Learning Reveals Sequence Features Driving Specificity in the CRISPR/Cas9 System
por: Vora, Dhvani Sandip, et al.
Publicado: (2023)

Molecular encapsulation of andrographolide in 2-hydroxypropyl-β-cyclodextrin cavity: synthesis, characterization, pharmacokinetic and in vitro antiviral activity analysis against SARS-CoV-2
por: Singh, Shashi Chandrama, et al.
Publicado: (2021)

A Machine Learning Approach to Identify the Importance of Novel Features for CRISPR/Cas9 Activity Prediction
por: Vora, Dhvani Sandip, et al.
Publicado: (2022)

CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri
por: Oh, Jee-Hwan, et al.
Publicado: (2014)

CRISPR-Cas12a-Assisted Recombineering in Bacteria
por: Yan, Mei-Yi, et al.
Publicado: (2017)

CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion
por: Krohannon, Alexander, et al.
Publicado: (2022)

CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer
por: Deepak Singh, Desh, et al.
Publicado: (2021)

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
por: Rahman, Mujeeb ur, et al.
Publicado: (2022)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

A Landscape of CRISPR/Cas Technique for Emerging Viral Disease Diagnostics and Therapeutics: Progress and Prospects
por: Tripathi, Shyam, et al.
Publicado: (2022)

CRISPR/Cas-based customization of pooled CRISPR libraries
por: Kweon, Jiyeon, et al.
Publicado: (2018)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

Special focus CRISPR-Cas
por: Marchfelder, Anita
Publicado: (2013)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

CRISPR-Cas in Streptococcus pyogenes
por: Le Rhun, Anaïs, et al.
Publicado: (2019)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

CRISPR-Cas-Integrated LAMP
por: Atçeken, Nazente, et al.
Publicado: (2022)

CRISPR-Cas12a-assisted nucleic acid detection
por: Li, Shi-Yuan, et al.
Publicado: (2018)

WeReview: CRISPR Tools—Live Repository of Computational Tools for Assisting CRISPR/Cas Experiments
por: Torres-Perez, Rafael, et al.
Publicado: (2019)

Bioengineering of fungal endophytes through the CRISPR/Cas9 system
por: Verma, Vinita, et al.
Publicado: (2023)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

CaSilico: A versatile CRISPR package for in silico CRISPR RNA designing for Cas12, Cas13, and Cas14
por: Asadbeigi, Adnan, et al.
Publicado: (2022)

Exploiting the CRISPR/Cas9 PAM Constraint for Single-Nucleotide Resolution Interventions
por: Li, Yi, et al.
Publicado: (2016)

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
por: Bhardwaj, Shanu, et al.
Publicado: (2021)

Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity
por: Landsberger, Mariann, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n8o9u6nmah76e0rc5hkkm2e7a7